At Metabolon, we have spent the last 20 years building the best metabolomic competency in the world. Today, we enable, accelerate, and support drug development through biomarker discovery, understanding mechanism of action, patient stratification and more. One tool we use to power our work is machine learning, which automates routine tasks and teachable processes so our experts can focus their efforts on the challenges that most require their expertise.
Metabolomic data can play a pivotal role in understanding critical questions across the life sciences—the launch of DNA Genotek’s OMNImet.GUT validated by Metabolon dramatically expanded the accessibility of metabolomics for gut microbiome studies. This milestone shows how Metabolon can deliver innovative metabolomic insights through other collaborations.
A successful metabolomics study requires a comprehensive approach focused on quality and accuracy. That's why choosing the right partner can yield many more insights than trying to go it on your own, all while avoiding expensive mistakes. Consider these four risks that come with trying to do a metabolomics analysis without support.
3 Ways Machine Learning Propels Metabolomics at Metabolon
Metabolon and DNA Genotek: Collaborating to Advance Functional Understanding of the Microbiome
For a Successful Metabolomics Study, Don’t Risk Going it Alone
Achieve Study Success with Metabolon’s New Sample Handling Kit: Designed with Experience
Metabolon: A Rich Past and A Promising Future
An interview with the Founder and CEO of Siolta
There is Truth to the Adage “Get Your Beauty Rest”
The Road Less Traveled: The Faster Path to Biological Insights
Research shows that acetaminophen has unexpected effects on regulation of sex hormones
Metabolomics Needs Precision: The Case for Mass Spectrometry